Disease stabilization was also seen in multiple myeloma patients treated with the MUC1 signal peptide [17] and in pancreatic cancer patients treated with dendritic cells pulsed with a 100-mer peptide [18]. This evidence concerns the gene MUC1 and pancreatic neoplasm.